期刊文献+

小剂量甲状腺素治疗顽固性心功能不全临床观察 被引量:2

Clinical observation of therapeutic efficacy of low dose thyroxine in patients with intractable heart insufficiency
下载PDF
导出
摘要 目的:探讨小剂量甲状腺素治疗顽固性心功能不全的疗效。方法:26例经2周常规治疗效果不佳者作为治疗组,同期随机未予以甲状腺素治疗者19例为对照组,治疗组加甲状腺素20mg 1次/日,口服1月,观察、随访治疗前、后心功能、心脏射血分数(EF)、左室短轴缩短率(FS)、左室舒张期内径(LVDd)和血T3值的变化。结果:治疗组治疗后心功能明显改善,心脏射血分数增加,左室内径缩小(P<0.01),与对照组比较具有显著性差异(P<0.05),治疗组在治疗期间无不良反应发生。结论:小剂量甲状腺素治疗顽固性心功能不全是可取的。 Objective: To investigate the effect of thyroxine on patients with intractable heart insufficiency. Methods: The 45 patients with intractable, chronic heart insufficiency were randomly divided into 2 group, 29 cases of observation group and 19 cases of control group. All of them were received routine treatment, the group of observation received thyroxine (20mg/d oral, for one mouth) also. The cardiac function degree (NYHA) , Cardiac ejection fraction (EF), FS, Left ventricular diastolic internal diameters (LVDd) and value of T3 were measured before and after treatment. Results:The value of EF, FS, T3 and function were notably improved and the value of LVDd was notably descended as compared with those of the control group (P<0. 05). There were no significant side-effects in observation group in period of treatment. Conclusion: Low dose thyroxin can be used to treat the chronic and intractable heart insufficiency.
作者 李家岭
出处 《心血管康复医学杂志》 CAS 2004年第5期450-452,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 治疗组 甲状腺素 顽固性 心功能不全 小剂量 左室 对照组 心脏射血分数 临床观察 疗效 <Keyword>yroxin Intractable heart insufficiency Therapeutic efficiency
  • 相关文献

参考文献7

二级参考文献31

  • 1张玉顺 李寰(等).甲状腺激素治疗心血管疾病的研究进展[J].心血管病学进展,1998,19(5):28-28.
  • 2Fleck E, Harding S, Regitz Z. Heart failure:clinical aspects from basic research. Eur Heart J, 1994,15(SuppI D):2.
  • 3Hollard F W.Brown PS,Clark RE.Acute severe postischemic myocardial depression reversed by triiodothyronine[J].Ann Thorac Surg,1992,54:301.
  • 4Kiss E,Jakab G,Kranias EG,et al.Thyroid hormone induced alterations in phospholamb an protein expression.Regulatory effects on sarcoplasmic reticulum Ca 2+ transport and myocardiol relaxation[J].Circ Res,1994,75:245.
  • 5Hamilton MA,Stevenson LW,Luu M,et al.Altered thyroid hormone metabolism in advanced heart failure[J].JACC,1990,16:91.
  • 6Hamilton MA.Prevalence and clinical implications of abnormal thyroid hormone metabolism in advance heart failure[J].Am Thorac Surg,1993,56:s48.
  • 7Klein I.Levey GS.New perspectives on thyroid hormone catecholamines and the heart[J].Am J Med,1984,76:167.
  • 8Schrier RM, Abraham WT. Hormones and hemodynamic in heart failure[J]. N Engl J Med, 1999,341(8):577~585
  • 9Harmilton MA, Stevenson LW, Luu, M et al. Altered thyroid hormone metabolism in advanced heart failure[J]. JACC, 1990,16:91~95
  • 10Morkin E, pennock GD, Ray TE, et al. Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure[J]. Ann Thac Surg, 1993,56:54~60

共引文献61

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部